Request Deal Involvement
Bristol Myers Squibb completed the acquisition of Karuna Therapeutics from PureTech for $12.7bn.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors to financial advisors
Sullivan & Cromwell
legal advisors
Simpson Thacher & Bartlett
financial advisors
Goldman Sachs
financial advisors
Citigroup
financial advisors
Gordon Dyal & Co
legal advisors
Covington & Burling
pr advisors
Joele Frank
pr advisors
FTI Consulting
pr advisors
Ten Bridge Communications
or
Principals
target
KARUNA THERAPEUTICS
bidder
BRISTOL MYERS SQUIBB COMPANY
vendor
PURETECH HEALTH
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite